Bioavailability of antisense oligonucleotides in neuroblastoma cells: Comparison of efficacy among different types of molecules

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 171-180

  Corrias, Maria Valeria ^a   Guarnaccia, Francesco ^a   Ponzoni, Mirco ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Antisense; Capped oligonucleotides; Intracellular distribution; Neuroblastoma; Oligonucleotides; Uptake

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL MEMBRANE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG UPTAKE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL;

AUTORADIOGRAPHY; CELL MEMBRANE PERMEABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EVALUATION STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; OLIGONUCLEOTIDES, ANTISENSE; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 0031050645     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005726623591     Document Type: Article

References (31)

1. Stein CA, Cheng YC: Antisense oligonucleotides as therapeutic agents. Is the bullet really magical? Science 261: 1004-1012, 1993
2. Neckers L, Whitesell L: Antisense technology: biological utility and practical considerations. Am J Physiol L1-12, 1993
3. Mirabelli CK, Bennett CF, Anderson K, Crooke ST: In vitro and in vivo pharmacologic activities of antisense oligonucleotides. AntiCancer Drug Design 6: 647-661, 1991
4. Crooke RM: In vitro toxicology and pharmacokinetics of antisense oligonucleotides. AntiCancer Drug Design 6: 609-646, 1991
5. Wang S, Dolnick BJ: Quantitative evaluation of intracellular sense: antisense RNA hybrid duplexes. Nucleic Acids Res 21: 4383-4391, 1993
6. Ramanthan M, Mac Gregor RD, Hunt CA: Predictions of effect for intracellular antisense oligodeoxyribonucleotides from a kinetic model. Antisense Res Devel 3: 3-18, 1993
7. Bennet CF, Chiang M-Y, Chan H, Shoemaker JEE, Mirabelli CK: Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41: 1023-1033, 1992
8. Krieg AM, Tonkinson J, Matson S, Zhao Q, Saxon M, Zhang L.M, Bhanja U, Yabukov L, Stein CA: Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci 90: 1048-1052, 1993
9. Thierry AR, Dritschilo A: Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res 20: 5691-5698, 1992
10. Zhao Q, Matson S, Herrera CJ, Fisher E, Yu H, Krieg AM: Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Devel 3: 53-66, 1993
11. Loke SL, Stein CA, ZhangXH, Mori K, NakanishiM, Subasinge C, Cohen JS, Neckers LM: Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci 86: 3474-3478, 1989
12. Geselowitz DA, Neckers LM: Analysis of oligonucleotide binding, internalization and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res Devel 2: 17-25, 1992
13. Seeger RC, Danon YL, Rayner SA, Hoover F: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 128: 983-989, 1982
14. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS: Multiple neurotransmitter synthesis by human neuroblastoma cells lines and clones. Cancer Res 38: 3751-3757, 1978
15. Longo L, Christiansen H, Paulsen P, Cornaglia-Ferraris P, Lampert F: N-myc amplification at the chromosome band 1p32 in neuroblastoma cells as investigated by in-situ hybridization. J Cancer Res Clin Oncol 114: 63-640, 1988
16. Ponzoni M, Casalaro A, Lanciotti M, Montaldo PG, Cornaglia-Ferraris P: The combination of γ-interferon and Tumor Necrosis Factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res 52: 931-939, 1992
17. Benech B, Mory Y, Revel M, Chebath J: Structure of two forms of the interferon induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J 4: 2249-2256, 1985
18. Corrias MV, Gribaudo G, Guarnaccia F, Ponzoni M: Induction of 2.5 OAS gene expression and activity is not sufficient for IFN-γ-induced neuroblastoma cell differentiation. Int J Cancer 1995 (in press)
19. Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG: Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 55: 853-861, 1995
20. Graham J: Isolation of subcellular organelles and membranes. In: Centrifugation: A Pratical Approach. 2nd edition. IRL press, Oxford, UK, 1990, pp 161-182
21. 2 activation in human neuroblasts. Biochem J 294: 893-898, 1993
22. Iwanaga T, Ferriola PC: Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by cell density in a transformed rat tracheal epitelial cell line: implication for antisense approaches. Biochem Biophys Res Comm 191: 1152-1157, 1993
23. 3H] Thymidine incorporation by "control" oligonucleotides. Antisense Res Devel 2: 325-330, 1992
24. Smetsers TF, Skorki T, Van De Locht LT, Wessels HM, Pennings AH, Dewittet T, Calabretta B, Mensink EJ: Antisense bcr-abl oligonucleotides induce apoptosis in the Philadelphia cromosome-positive cell line BVI73. Leukemia 8: 129-140, 1994
25. Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A, Raschellà G: Decrease of proliferation rate and induction of differentiation by N-myc antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 2: 511-518, 1991
26. Holt JT, Redner RL, Neinhuis AW: An oligomer complementaryto c-myc mRNA inhibits proliferation of HL60 promyelocitic cells and induces differentiation. Mol Cell Biol 8: 963-972, 1988
27. Yabukov LA, Deeva EA, Zarytova F, Ivanova IM, Ryte AS, Yurchinski L, Vlassov VV: Mechanisms of oligonucleotides uptake by cells: involvement of specific receptors? Proc Natl Acad Sci 86: 6454-6459, 1989
28. Boutorin AS, Gusílova LV, Ivanova EM, Kobetz ND, Zaritova VF, Ryte AS, Yurkhenco LV, Vlassov VV: Synthesis of alkilating oligonucleotide derivatives containing cholesterol or phenzinium residues at their 3′ terminus and their interaction with DNA within mammalinan cells. FEBS Lett 254: 129-132, 1989
29. Leonetti JP, Degols G, Clarenc P, Mechti N, Lebleu B: Cell delivery and mechanisms of action of antisense oligonucleotides. Prog Nucl Ac Res 44: 142-165, 1993
30. Perez JR, Li YL, Stein CA, Majiumder S, Vanoorschot A, Narayanan R: Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci 91: 5957-5961, 1994
31. Falker B, Herlitze S, Amthor B, Zenner HP, Ruppersberg JP: Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo lenght and concentration but almost independent of location of the target sequence. J Biol Chem 269: 16187-16194, 1994